StockData
Sight Sciences, Inc. logo

Sight Sciences, Inc. (SGHT) stock

SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30167% above fair value
$10.62−0.15 (-1.39%)

Close on Nov 19, 2026Market cap $585.03MP/E –Yield –

Sight Sciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Sight Sciences's revenue for the twelve months ending Jun 30, 2026 was $83.38M, up 9.3% year over year. For fiscal 2025 it was $77.36M, down 3.1% from the year before. The highest annual figure on record is $81.06M in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$77.36M-3.1%
FY2024Dec 31, 2024$79.87M-1.5%
FY2023Dec 31, 2023$81.06M+13.6%
FY2022Dec 31, 2022$71.33M+45.7%
FY2021Dec 31, 2021$48.96M+77.1%
FY2020Dec 31, 2020$27.64M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$23.39M+19.5%
Q1 FY2026Mar 31, 2026$19.70M+12.5%
Q4 FY2025Dec 31, 2025$20.39M+6.9%
Q3 FY2025Sep 30, 2025$19.91M-1.2%
Q2 FY2025Jun 30, 2025$19.56M-8.5%
Q1 FY2025Mar 31, 2025$17.51M-9.1%
Q4 FY2024Dec 31, 2024$19.07M+1.7%
Q3 FY2024Sep 30, 2024$20.16M+0.7%
Q2 FY2024Jun 30, 2024$21.37M-9.0%
Q1 FY2024Mar 31, 2024$19.27M+2.3%
Q4 FY2023Dec 31, 2023$18.75M-8.7%
Q3 FY2023Sep 30, 2023$20.01M+7.1%
Q2 FY2023Jun 30, 2023$23.47M+36.2%
Q1 FY2023Mar 31, 2023$18.82M+26.5%
Q4 FY2022Dec 31, 2022$20.54M+39.9%
Q3 FY2022Sep 30, 2022$18.68M+42.6%
Q2 FY2022Jun 30, 2022$17.23M+37.4%
Q1 FY2022Mar 31, 2022$14.88M+72.3%
Q4 FY2021Dec 31, 2021$14.69M+63.3%
Q3 FY2021Sep 30, 2021$13.10M+51.4%
Q2 FY2021Jun 30, 2021$12.54M+257.9%
Q1 FY2021Mar 31, 2021$8.64M–
Q4 FY2020Dec 31, 2020$8.99M–
Q3 FY2020Sep 30, 2020$8.65M–
Q2 FY2020Jun 30, 2020$3.50M–

More Sight Sciences figures

See a number that looks wrong?